Corebridge Financial Reports Strong Q2 GAAP Turnaround, Shareholders Approve Equitable Merger
CRBG sits 50% above its 52-week low of $22.19.
Summary
Corebridge Financial reported a significant improvement in Q2 and year-to-date GAAP net income and EPS, driven by lower realized losses, and confirmed shareholder approval for its all-stock merger with Equitable Holdings.
Key Events · Earnings and Guidance · CRBG
-
Q2 GAAP Net Income Turnaround
Reported $2 million net income for Q2 2026, a substantial improvement from a $668 million net loss in Q2 2025. Year-to-date net loss also significantly narrowed to $59 million from $1.325 billion.
-
Shareholders Approve Equitable Merger
Shareholders of both Corebridge and Equitable Holdings approved the all-stock merger on July 30, 2026, with the transaction expected to close by year-end 2026.
-
Significant Share Repurchases
The company repurchased approximately $1.6 billion of common stock year-to-date, including $300 million in Q2 2026, with $1.0 billion remaining under the current authorization.
-
Decline in Adjusted Operating Income
Adjusted pre-tax operating income (APTOI) decreased by $178 million in Q2 and $259 million year-to-date, primarily due to higher policyholder benefits and interest credited to policyholder accounts.
Analysis · CRBG · Finance
Corebridge Financial reported a significant turnaround in GAAP net income and EPS for Q2 and year-to-date, moving from substantial losses to near break-even in Q2. This improvement was primarily driven by lower net realized losses. Crucially, shareholders of both Corebridge and Equitable Holdings have approved the all-stock merger, removing a key uncertainty and paving the way for the transaction to close by year-end 2026. The company also continued its robust share repurchase program, buying back $1.6 billion year-to-date, signaling strong capital return to shareholders. While adjusted operating income saw a decline and the deferred tax asset valuation allowance increased, these negatives are largely overshadowed by the positive GAAP performance and the finalization of the merger.
At the time of this filing, CRBG was trading at $33.30 on NYSE in the Finance sector, with a market capitalization of approximately $14.8B. The 52-week trading range was $22.19 to $36.57. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.